Introduction
Anthelmintic resistance in nematode populations and concerns about the effects of drug residues on consumer health and the environment have focused attention on the prospect of developing effective anti-nematode vaccines. These studies focus on characterizing the host anti-parasite immune response, the nature of the protective components of the response, the parasite life-cycle stage targeted and, ultimately, from a vaccine development point of view, identifying the antigens stimulating it. Technological developments in molecular biology have accelerated the process with the prospect of being able to produce even the least abundant antigen in limitless quantity. In addition, functional genomics approaches are used for antigen identification while rapid developments in immunology allow the more precise definition of protective as opposed to irrelevant or harmful immune responses. These developments have, in turn, led to enhanced and very selective means of antigen delivery while recent advances in 'naked' DNA vaccination point to a future where antigen is delivered to the host immune system along with the cell signals required to initiate the desired immune response. Therefore, vaccination is feasibleor is it?
Host and parasite have coevolved over millions of years and exist in mutual tolerance, disease only being apparent when the balance is upset by the host being exposed to unusually high parasite burdens at times when immunocompetence is diminished by age, physiological state, disease or nutritional status. The host immune response is multifaceted and it is ©CAB International 2001. Parasitic Nematodes (eds M.W. Kennedy and W. Harnett) difficult to dissect it to the extent of claiming that a particular component solely mediates protective immunity. Imbalances in this immune response are often the physical manifestations of parasite-induced disease. Susceptibility and resistance to parasite infection certainly have a host genetic basis and are likely to be influenced by parasite genetics in that some parasite genotypes may be more virulent than others. Therefore, vaccine development based on antigens that stimulate protective host immune responses during the course of infection may not be as straightforward as might be anticipated. An alternative approach is initially to ignore the host immune response and focus on parasite proteins that may be essential to parasite survival, such as excretory/secretory (ES), cuticular or gut-expressed proteins. This chapter will focus on vaccination against nematode parasites based on proteins isolated from the surface of the gut.
The Nematode Gut
The nematode gut comprises, from anterior to posterior, a buccal capsule, a muscular pharynx, a fairly straight intestine which is a single cell thick and, finally, a rectum or cloaca. The pharynx and cloaca are, in part, lined with cuticle while the surface of the intestinal cells facing the lumen have microvilli (Bird, 1971) . Oesophageal glands, one dorsal and two subventral, open into the base of the buccal capsule, while the oesophagus is separated from the intestine by the oesophago-intestinal valve (Colam, 1971) . The length of the microvilli varies with nematode species from, for example, 1 µm in adult Nippostrongylus brasiliensis (Jamaur, 1966) to 5.5 µm to 7.5 µm in Haemonchus contortus (Fig. 13 .1) (Munn, 1977) . In strongylid nematodes, there is a fibrous submicrovillar layer to which the filamentous cores of the microvilli attach (Munn, 1977) and this layer, together with the microvilli, can be dissected from the remainder of the intestine. The product is tubular and has been termed the endotube because of its intracellular origin (Munn, 1981) . Endotubes are present in 12 different species of strongylid (Munn and Greenwood, 1983) and are generally absent in non-strongylid orders. The endotube is presumed to be cytoskeletal but can undergo DTT/ATP-induced contraction (Munn and Greenwood, 1983 ).
Proteins at the Microvillar Surface Contortin
The microvillar surface is coated with a layer of electron-dense amorphous material (glycocalyx). In H. contortus, helical filaments composed of contortin are associated with this layer and fill the spaces between the microvilli. There can be up to ten strands of contortin in each microvillus; each is continuous from the base to the tip of the microvillus and many extend into the gut lumen (Munn, 1977) . Contortin is not attached to the plasma membrane and some lies free in the lumen of the intestine; it is also present in large amounts in the pharynx, though this may not be the case in vivo (Munn, 1977) . Contortin can be purified from phosphate-buffered saline extracts of adult parasites by ultra-centrifugation and is not, apparently, a glycoprotein. Over 90% of the material purified in this way has an apparent molecular weight of 60 kDa as judged by SDS-PAGE, the remainder being composed of contaminating membrane fragments. The spatial arrangement of contortin in the intestine is illustrated in a series of elegant electronmicrographs in Munn (1977) .
Vaccination of lambs with a contortin-enriched preparation gave a mean reduction in worm burdens of 78% (Table 13 .1) (Munn et al., 1987) . This result was particularly significant because it showed that proteins expressed on the surface of the gut, albeit from a blood-feeding nematode, could induce high levels of protective immunity when used as an immunogen. These proteins are not normally accessible to the host immune system during the course of infection; they are termed hidden or concealed antigens and the immunity conferred by them is described as artificial immunity.
Contortin-like material was also observed in Teladorsagia circumcincta, another stomach worm of ruminants, while material separating the microvilli of the rodent nematodes N. brasiliensis and Syphacia obvelata was Munn et al., 1987 Newton and Munn, 1999 Smith et al., 1994 Smith and Smith, 1996 Knox et al., 1999 Munn et al., 1997 Jasmer et al., 1993 Boisvenue et al., 1992 a Presumed (but not proven) to be derived from the gut. quite distinct in appearance compared with contortin. Contortin is quite an unusual biopolymer, being a flexible, helical and extracellular protein (Munn, 1977) .
H11
Contortin-enriched preparations also contained a 110 kDa major antigenic contaminant as judged by Western blotting, despite only faint staining being evident in protein gels (Smith and Munn, 1990) . This protein has been purified using concanavalin A lectin-affinity chromatography combined with, on some occasions, Mono Q anion-exchange chromatography and it migrates as a doublet at 110 kDa as judged by SDS-PAGE, hence the short-hand designation, H11. It is the most effective immunogen isolated from a parasitic nematode to date, inducing high levels of protection against challenge in recipient lambs (Table 13 .1). It is highly effective in inducing protection in a range of sheep breeds, in very young lambs and in pregnant ewes, and is effective against anthelmintic-resistant H. contortus (reviewed by Newton and Munn, 1999) . The protection persists for at least 23 weeks . Moderate levels of protection are transferred to the newborn lamb via colostrum (Andrews et al., 1995) indicating that protective immunity is antibody mediated. It is highly effective when administered in the ethically acceptable adjuvant, QuilA. Despite H11 being defined as a hidden antigen, it is interesting to note that the immune response in sheep, primed by immunization, is boosted by H11 released from dead or dying parasites . For these reasons, intensive work is now in progress to develop a recombinant vaccine against haemonchosis. H11 is an integral membrane glycoprotein which is only expressed on the intestinal microvilli of the parasitic stages. It shows microsomal aminopeptidase A and M activities and is expressed as three isoforms (Graham et al., 1993; Smith et al., 1997) . H11 has the predicted structure of a type II integral membrane protein with a short N-terminal cytoplasmic tail, a transmembrane region and an extracellular region organized into four domains (Newton and Munn, 1999) with three N-linked glycosylation sites . There is an HEXXHXW sequence motif followed by a glutamic acid which is a characteristic of the zinc-binding sequence of microsomal aminopeptidases. Enzyme activity is localized exclusively in the microvilli and is inhibited by the aminopeptidase-specific inhibitors bestatin and amastatin and by the chelating agent phenanthroline . H11 antisera inhibit the aminopeptidase activity in vitro and the level of inhibition observed is closely correlated to protection. Protection levels are reduced by dissociation and denaturation , observations that indicate the involvement of conformational epitopes in the induction of immunity. The three isoforms have been expressed as enzymically active recombinant proteins using the baculovirus-Sf 9 insect cell system and the outcome of protection trials is awaited. In addition, full-length cDNAs and defined fragments have been expressed in Escherichia coli (Newton and Munn, 1999) .
Homologues of H11 are present in T. circumcincta and Ostertagia ostertagi and are currently being evaluated in protection trials. Moreover, aminopeptidase activity is present in the intestinal microvilli of the human hookworm Necator americanus (McLaren et al., 1974) and this activity can be solubilized from the intestinal brush border using detergents. This material also contains a protein doublet at 110 kDa which may be a homologue of H11 and may have utility in developing molecular vaccines against hookworm infection in humans . In addition, pigs immunized with aminopeptidase purified from the gut of adult Ascaris suum were protected against challenge infection, as judged by a 50% reduction in larval counts compared with challenge controls (Ferguson et al., 1969) . A recent study reported that sheep vaccinated with leucine aminopeptidase purified from adult Fasciola hepatica were highly (89%) protected against metacercarial challenge (Piacenza et al., 1999) . All the experiments cited emphasize the potential generic utility of gut-expressed aminopeptidases as anti-nematode vaccine components.
GA1 antigens
Monoclonal antibodies were used to probe gut surface antigens from H. contortus which may be associated with protective immunity and which may be phylogenetically conserved. One of the monoclonal antibodies recognized a carbohydrate epitope on several proteins and it was also identified in related adult and larval nematodes, including O. ostertagi, Trichostrongylus colubriformis and Caenorhabditis elegans but not Trichinella spiralis (Jasmer et al., 1993) . This monoclonal antibody was subsequently used, in a generic manner, to identify other membrane and secreted proteins from Haemonchus, several of which were novel and others that had been described previously (Rehman and Jasmer, 1998) . A different monoclonal antibody, with specificity for H. contortus only, was used to identify and purify a group of proteins, M r 46, 52 and 100 kDa, which, collectively, induced reductions of 60% and 50% in worm and faecal egg outputs, respectively, in immunized goats.
N-terminal protein sequence analyses of the three proteins, termed p46 GA1 , p52 GA1 and p100 GA1 , and cDNA library immunoscreening showed that all three were encoded by the same GA1 gene and are initially expressed as a polyprotein (p100 GA1 ). The individual proteins could be released by serine protease-mediated cleavage (Jasmer et al., 1996) ; p100 GA1 and p46 GA1 shared the same N-terminal sequence while that of p52 GA1 was located midway through the predicted protein sequence derived from a full-length cDNA encoding p100 GA1 . Western blot analysis indicated that the GA1 proteins were expressed in adult worms but not in infective larvae, a result essentially confirmed by Northern blot analysis. The GA1 gene product showed closest homology with bacterial Tolb proteins, which are associated with the bacterial membrane and periplasm and may be involved in transport. All GA1 proteins and the Tolb protein shared a consensus Ser-Pro-Asp-Gly sequence, which was repeated in both proteins with identical spacing between the repeats (Jasmer et al., 1996) . p52 GA1 contained a glycosylinositolphospholipid anchor indicative of an integral membrane protein while p46 GA1 lacked obvious sequences normally associated with membrane insertion, indicating apical gut membrane association via a distinct mechanism (Jasmer et al., 1996) .
GA1-derived proteins were detected in ES products from adult worms and host abomasal mucus, indicative of release from the microvillar surface. Following from this, protective immunity stimulated by immunization with these proteins may involve anamnestic and mucosal immune responses. This suggestion was supported in a later study (Karanu et al., 1997a) , which provided evidence for a contribution from CD4 + lymphocytes to gut antigen-induced immunity.
P150
During the course of developing procedures for the purification of H11 to homogeneity, identified a group of three peptides that were separated from ConA lectin-binding H11 by ion-exchange chromatography. The constituent peptides (45, 49 and 53 kDa) showed some similarities to the GA1 proteins and induced mean reductions of 69% in faecal egg output and 38% and 20% reductions in female and male worm numbers, respectively . The proteins, designated P45, P49 and P53, form a complex (P150) which is a ubiquitous constituent of the microvillar membrane of the intestinal cells. P53 has a membrane anchor and associates non-covalently with a disulphide bridged dimer of P45 and P49. All three components share peptide epitopes (Rocha and Munn, 1997) . Smith et al. (1994) used several different techniques, including lectin screening of worm sections and radio-labelling, to target integral membrane glycoproteins on the luminal membrane of H. contortus gut. These proteins were then purified from detergent extracts of whole worms and evaluated in protection trials. One fraction, which selectively bound to lectins with specificity for N-acetylgalactosamine, reduced mean challenge worm burdens by up to 72% and mean faecal egg counts by up to 93%.
H-gal-GP
This fraction was termed Haemonchus galactose-containing glycoprotein complex (H-gal-GP). The microvillar surface of the intestinal cells of worms retrieved from vaccinated lambs was coated with sheep immunoglobulin and protection observed, over a series of trials, was correlated with systemic antibody titre .
H-gal-GP can be visualized as a single diffusely staining band after Blue Native PAGE with an estimated molecular weight of about 1000 kDa and resolves as four major protein zones, designated A, B, C and D, at approximately 230, 170, 45 and < 35 kDa, respectively, under non-reducing conditions . Each zone resolved as more than one band after reduction. Biochemical analyses indicated that H-gal-GP exhibited aspartyl, metallo-and, on occasion, cysteine protease activities. N-terminal sequence analysis of the individual peptide components from the four major protein zones showed clear homology with pepsin and metalloprotease cDNAs recently isolated from Haemonchus ( Fig. 13 .2) (Longbottom et al., 1997; Redmond et al., 1997; Smith et al., 1999) .
The pepsin, activated by cleavage of a proenzyme, has two putative active site domains comprising hydrophobic-hydrophobic-Asp-Thr-Gly amino acids, is potentially glycosylated and has a free cysteine residue which may allow it to form dimers, as in the case of human and Plasmodium falciparum-derived aspartyl proteases (Longbottom et al., 1997) . However, this suggestion is not supported by non-reducing SDS-PAGE analysis. It also contains additional amino acid insert sequences, in particular one of 23 amino acids, as well as a five amino acid deletion, compared with human and porcine pepsin. The functional significance of these sequence changes is undefined at present. The metalloprotease MEP1 showed closest homology to mammalian neutral endopeptidases , which are type II integral membrane proteins and have diverse tissue localization patterns, including the microvillar surfaces of the kidney and intestine (Rocques et al., 1993) . Neutral endopeptidases are zinc-dependent proteases and are responsible for the degradation of pharmacologically active peptides in nervous and peripheral tissues. MEP1 contains all the critical amino acids and motifs associated with the neutral endopeptidases, including a consensus active site sequence VxxHExxH which, in MEP1, is VVGHELVH, where the two histidines are putative zinc-coordinating ligands and the glutamate plays a role in catalysis by polarizing a water molecule. Southern blot analysis indicated that Haemonchus contained more than one MEP and this has been confirmed with a combination of cDNA library screening and N-terminal amino acid sequencing, which has shown that H-gal-GP contains at least four distinct MEPs with 38-54% identity at the amino acid level.
The N-terminal sequence of one peptide from the 35 kDa zone of H-gal-GP showed some homology to cathepsin B-like cysteine proteases. Molecular cloning has also identified a thrombospondin homologue associated with the diffusely staining region between zones A and B, a galectin associated with zone D and a low molecular weight (approximately 13 kDa) cysteine protease inhibitor, cystatin.
H-gal-GP has proved resistant to fractionation using a variety of chromatographic techniques under native conditions. Various analyses consolidate the view that H-gal-GP is a genuine complex of proteins with zones A to D being held together electrostatically and subunits of three of the four zones associating by disulphide bonding . With one exception, the subunits contain N-linked glycans and, despite behaving like an integral membrane protein, it remains unclear how H-gal-GP is anchored to the membrane.
So, what does the complex do? It could be a multi-protease complex crucial for digesting the blood meal and protease components are clearly localized to the microvillar surface of the intestinal cells (Fig. 13.3) . Certainly, the pepsin shows strong haemoglobinase activity with optimal activity at pH 4, which would be consistent with a worm living in the highly acidic environment of the ruminant true stomach. The MEPs are also likely to be involved in digestion but could also degrade peptides ingested with the blood meal, which may have adverse effects on the worm. It is worthy of note that MEPs and aminopeptidases co-localize in the mammalian kidney brush border and are both required to deactivate biologically active peptides. H11 is, of course, an amino-peptidase. Perhaps the proteases of H-gal-GP and H11 do not simply have a digestive function but protect the parasite from ingested toxic proteins.
Thrombospondins are multi-domain glycoproteins which, amongst other roles, have been implicated in attachment of Plasmodium-infected erythrocytes to endothelial cells (Roberts et al., 1985) whilst a Plasmodium sporozoite-derived thrombospondin homologue (TRAP) participates in invasion of host liver cells (Robson et al., 1988) . Could the thrombospondin component of H-gal-GP immobilize or trap red blood cells in the worm intestine to facilitate proteolytic lysis of the red blood cell, releasing haemoglobin for digestion by pepsin and gut-expressed cysteine proteases (see below)? The predicted thrombospondin amino acid sequence contains a number of repeat sequences with homology to Kunitz-type protease inhibitors and anticoagulants such as snake venom. It is possible (but we have no evidence for this yet) that the inhibitors are cleaved and may serve an anticoagulant function in the gut lumen. However, a Kunitz-type molecule localized to the gut, parenchymal tissue and tegument of the trematode F. hepatica has recently been characterized (Bozas et al., 1995) and did not inhibit key serine proteases of the bloodcoagulation pathway. Another possibility is that the inhibitors play some role in regulating parasite serine protease activities and it is worthy of note that the Thiol-Sepharose binding proteins, described below, include a gut-derived serine protease. The galectins are soluble lectins which specifically bind β-galactoside sugars and have diverse roles in cell adhesion, immune function and apoptosis. The H-gal-GP-associated galectins are tandem repeat-type galectins, having two carbohydrate recognition domains . These could act as a molecular glue holding elements of the complex together, though this idea is not supported by the observation that removal of the galectin with lactose did not affect the mobility of H-gal-GP in native gels . Galectin thus purified was ineffective in a protection trial. In contrast, galectins were dominant proteins in a fraction from T. circumcincta which stimulated protective immunity in lambs (Meeusen, 1995) . The cystatin has been cloned and expressed as a functionally active recombinant protein in E. coli using the plasmid pET22b + (G.F.J. Newlands, P.J. Skuce and D.P. Knox, 2000, unpublished results) . It is a very potent inhibitor of the cysteine proteases expressed in the gut of adult Haemonchus and possibly regulates their activity. Again, however, it proved ineffective in a protection trial. None of the individual components of H-gal-GP which have been purified or recombinant proteins encoding it have, to date, individually conferred protection levels against challenge infection as high as those observed following vaccination with the whole complex. The protection conferred by vaccination with H-gal-GP was relatively unaffected by dissociation or reduction of the immunogen prior to administration, indicating that protection was not dependent on conformational epitopes . The same authors tested the main components of H-gal-GP, which were simply excised from non-reducing SDS-PAGE gels prior to use as potential immunogens. Variable degrees of protection were observed between individual lambs when different excised bands were compared but in no case was the protection significant. and are being evaluated as protective antigens in the former two species. Preliminary results encourage cautious optimism, with moderate levels of protection being observed in some trials (W.D. Smith, 2000, unpublished results).
Homologues of H-gal-GP have been identified in O. ostertagi, T. circumcincta and Trichostrongylus vitrinus

Cysteine proteases
Cysteine proteases have long been implicated in the digestion of the blood meal in schistosomes, Fasciolidae and hookworms (reviewed by Tort et al., 1999) and, in the case of F. hepatica, are practically useful protective immunogens for bovine fasciolosis (Dalton et al., 1996) and, in combination with leucine aminopeptidase (Piacenza et al., 1999) , for ovine fasciolosis. Earlier work showed that extracts from adult H. contortus contained several strong cysteine protease activities and that these proteases had the capacity to degrade haemoglobin and albumin, major constituents of the blood meal. They also degraded fibrinogen and plasminogen, indicating a possible anticoagulant role. These studies have been elegantly extended by the demonstration that ES cysteine proteases from the adult parasite also degraded fibrinogen, haemoglobin, collagen, IgG and albumin (Rhoads and Fetterer, 1995) , degradation being attributable to cathepsin L-like proteases. Moreover, L4 and adult H. contortus maintained in the presence of a [ 3 H]-labelled extracellular matrix, readily degraded glycoprotein, collagen and elastin components of the matrix, degradation being blocked by a specific cysteine protease inhibitor . However, in vitro uptake of radiolabelled haemoglobin by adult parasites was not inhibited by the cysteine protease inhibitor, although haemoglobin breakdown in the culture medium was reduced by 50% . These observations suggest that cysteine proteases are functional in the extracorporeal digestion of the blood meal but are not required for uptake of the products. The latter function may be mediated by metallo-and serine proteases, given that uptake is markedly reduced in the presence of 1, 10 phenanthroline, an inhibitor of metalloproteases, and AEBSF, an inhibitor of serine proteases. Are these metalloproteases the MEPs found in H-gal-GP and is the serine protease a component of TSBP, described below?
Water-soluble extracts of adult H. contortus were shown to contain a 35 kDa cysteine protease which degraded fibrinogen and increased clotting time in sheep plasma in vitro . Lambs immunized with extracts from the adult parasite enriched for this activity were substantially protected against challenge infection (Boisvenue et al., 1992) . The cDNA (AC1) encoding this protease was isolated and showed 42% amino acid sequence identity to human cathepsin B. It encoded a protease predicted to comprise 342 amino acids, including a 15 amino acid hydrophobic N-terminal signal sequence. Genomic DNA analysis showed that the gene was a member of a small gene family (AC-1 to 5) expressed in the adult parasite, two of which are tandemly linked (Pratt et al., , 1992a . Primary structure comparisons suggest that members of the family may have differing substrate specificities and associated physiological functions. All contain potential signal sequences and may be secreted. However, no localization data have been reported, though Rehman and Jasmer (1999) were able to amplify AC-2 and AC-4 from a total gut RNA pool as well as a novel sequence encoding a cysteine protease designated hc.gcp7. A similar small gene family has been demonstrated in O. ostertagi (CP1-3) and, again, two of these are tandemly linked and show closer homology to the Haemonchus AC sequences than to cathepsin B (Pratt et al., 1992b) .
Membrane extracts from adult H. contortus were enriched 24-fold for cysteine protease activity by passage over a Thiol-Sepharose affinity column and the proteins obtained (abbreviated as TSBP) were clearly localized to the microvillar surface of the intestinal cells . TSBP comprised a prominent 60 kDa protein and several minor bands between 35 and 45 kDa and 97 to 120 kDa ( Fig. 13.2) . Protease activity at 38, 52 and 70 kDa was attributable to cysteine proteases and at 70 and 88 kDa to serine/metalloproteases, as judged by inhibition analyses. Lectin-binding studies showed that most of the TSBPs were glycosylated. Expression library (lambda gt11 and lambda ZAP) immunoscreening has revealed that the prominent 60 kDa component of TSBP is a glutamate dehydrogenase (GDH) homologue (Skuce et al., 1999a) and that the cysteine protease activity can be attributed to the protein products of three distinct genes, cDNAs derived from which have been designated hmcp1, 4 and 6 (Skuce et al., 1999b) .
Lambs immunized with TSBP were substantially protected against a single challenge infection with H. contortus, with reductions in daily faecal egg outputs of 77% and final worm burdens of 47% over three trials. Again, the microvillar surface of worms surviving in vaccinated lambs was coated with sheep immunoglobulin and recent experiments in our laboratory show that antibody harvested from vaccinated lambs functionally inhibits the cysteine protease components of TSBP (D.P. Knox, 2000, unpublished results) . Of interest, cysteine protease-enriched fractions prepared in the same way from water-soluble parasite extracts were ineffective immunogens. These extracts are likely to contain ES proteases and those present free in the gut lumen. To conclude that these proteases are not effective immunogens on the basis of this result is unsound because Thiol-Sepharose only interacts with free -SH groups and it is likely that ES cysteine proteases would only be present in whole worm extracts as inactive precursors.
Following identification of the GDH component by molecular cloning, enzyme activity was readily demonstrated in TSBP using a standard commercial kit. GDH expression is developmentally regulated, being restricted to the blood-feeding parasite stages. Immunolocalization studies showed that the enzyme was present in the cytoplasm of the intestinal cells, not the microvillar surface. This would argue against the GDH being the protective component of TSBP, as it would be inaccessible to antibody, and this, indeed, appears to be the case. TSBP can be further fractionated by anion exchange chromatography into a fraction that contains the bulk of the GDH protein and activity, fractions that contain the cysteine proteases and very little GDH, and a protein fraction that does not bind to the column . Lambs immunized with the GDH fraction, or the unbound protein fraction, were completely unprotected against challenge, whilst lambs immunized with the pooled protease-containing fractions were protected against challenge to the same degree as vaccination controls that received unfractionated TSBP , supporting the view that protection is attributable to the cysteine proteases.
The expression of the cysteine protease-encoding genes hmcp 1, 4 and 6 also coincides with the onset of blood feeding, and immunolocalization studies suggest that each was expressed at the luminal surface of the intestinal cells (Skuce et al., 1999b) . Like the other cysteine proteaseencoding genes characterized from H. contortus Pratt et al., 1990 Pratt et al., , 1992a Rehman and Jasmer, 1998) , hmcp 1, 4 and 6 showed closest homology to cathepsin B, with consensus signal and propeptide cleavage sites, a conserved Cys, His, Asn catalytic triad, 14 cysteine residues and a number of proline residues, all of which contribute to tertiary structure and suggesting that the tertiary structure should be similar to cathepsin B. This was confirmed by molecular modelling, an example of which is shown in Fig. 13.4 . Like cathepsin B, each contained a structural element, the occluding loop, which occludes the opening into the active-site cleft containing the catalytic triad. Of particular interest, key residues that determine substrate specificity differ between the hmcp sequences and cathepsin B , possibly conferring cathepsin L-like characteristics, a finding in accord with existing biochemical definitions of H. contortus cysteine proteases in ES (Rhoads and Fetterer, 1995) and TSBP (D.P. Knox, 2000, unpublished results) . Substitutions in active-site cleft residues which contribute to substrate binding have been suggested to contribute to the cathepsin L-like specificities of Ancylostoma caninum ES proteases (Brinkworth et al., 1996) and, conversely, cathepsin B-like specificity of a cathepsin L homologue from Toxocara canis (Loukas et al., 1998) . It remains to be seen whether this paradoxical substrate specificity is a common feature amongst nematode cysteine proteases.
For the development of anti-nematode vaccines with worldwide utility, geographical strain differences leading to antigenic diversity would be a serious concern. We have been unable to isolate any of the AC sequences Pratt et al., 1992) or gcp7 (Rehman and Jasmer, 1998) from UK isolates of H. contortus, either by gene-specific PCR or by immunoscreening. However, recent EST data (D. Jasmer, EMBL database) identified sequences encoding hmcp 1 to 4, AC3 and gcp7 from a USA strain. Inter-and intra-geographical isolate heterogeneity amongst proteases found in adult worm ES has also been reported (Karanu et al., 1997b) . Clearly, this diversity of protease expression requires further investigation before its possible implications for vaccine development can be established.
Gut Antigen-based Vaccination and Non-blood-feeders
Experiments to date, where homologues of H11, H-gal-GP and TSBP extracted from O. ostertagi or T. circumcincta have been evaluated in protection trials conducted in cattle and sheep, as appropriate, have generated inconclusive data. For example, in one trial, lambs vaccinated with TSBP purified from T. circumcincta were highly protected (71% reduction in egg output, 65% reduction in worms retrieved compared with challenge controls) against a single challenge infection but this level of protection could not be reproduced in two subsequent trials. An obvious explanation is that these parasites are ingesting insufficient antibody for the vaccine to be effective. Another possibility is that protection is absolutely dependent on the cysteine protease components of the vaccine being enzymically active and it is known that TSBPs are unstable. Another explanation lies in individual variation in the level of innate immunity. Lambs within a control experimental group, where age, sex and breed are the same and food intake is controlled, often show highly variable levels of susceptibility to challenge infection.
Of course, a protein target identified by homology to another nematode species may be less than appropriate. T. circumcincta and O. ostertagi do express equivalents of H11, H-gal-GP and TSBP but neither parasite is an obligate blood-feeder. Comparisons of ES proteases from these species and those from H. contortus (D.P. Knox and H.D.F. Schallig, 2000, unpublished results) indicate that the former are much less dependent on cysteine proteases, with metallo-and serine proteases being more prominent (Young et al., 1995) . Intestinal nematodes such as Trichostrongylus vitrinus tend to contain and secrete predominantly serine and metalloproteases (MacLennan et al., 1997) so perhaps successful vaccination with gut proteins may require species-specific selection of the protein target(s).
Glycosylation of Parasite Protein
Virtually all of the proteins described above are known to be, or predicted from gene sequence data to be, glycosylated. Because several (H11, H-gal-GP and GA1) can be separated from each other by lectin-affinity chromatography, glycosylation must vary depending on the protein. The nature of the N-linked oligosaccharides associated with proteins in detergent extracts of the adult parasite and with H11 specifically has been investigated in detail (Haslam et al., 1996 ; see also Chapter 15). These experiments identified a core fucosylation of a type not previously observed in eukaryotic glycoproteins. The major N-linked glycans had up to three fucose residues attached to chitobiose cores. These were found at the 3-and/or 6-positions of the proximal N-acetylglucosamine (GlcNAc) and at the 3-position of the distal GlcNAc. The latter substitution was stated to be unique in N-glycans (Haslam et al., 1996) . It was proposed that these multifucosylated core structures could be highly immunogenic.
Integral Membrane Proteins and Membrane Anchors
Of the integral membrane proteins referred to above, H11 has a distinct transmembrane region , the GA1 proteins are anchored via a glycosylinositolphospholipid (GPI) membrane anchor on p52, with p46 being held in place by as yet undefined interactions (Jasmer et al., 1996) . The P150 complex is anchored by a membrane (GPI) anchor on the 53 kDa component which forms non-covalent associations with the 45 and 53 kDa components (Rocha and Munn, 1997) . The means by which H-gal-GP and TSBP are anchored in the membrane is less clear. In the case of H-gal-GP, most components contain a predicted signal peptide, which is subsequently cleaved, and some contain potential transmembrane regions (though the latter require experimental confirmation). GPI anchoring is not involved . Hydrophobicity analyses suggest that MEP2, MEP3 and MEP4 all contain at least one short hydrophobic region which could serve as transmembrane helices (Fig. 13.5) . No regions of particular hydrophobicity were identified in MEP1, suggesting that this protein is held at the membrane by association with another membrane-anchored protein . A homologue of MEP1, designated MEP1b (Rehman and Jasmer, 1999) , has a signal peptide indicative of secretion. Perhaps MEP1 is, in fact, intracellular? The same type of analysis has identified two short regions in the pepsin homologue that may serve to anchor this molecule to the surface of the membrane. In the case of the cysteine protease components of TSBP, each contains consensus signal and pro-enzyme cleavage sites with no evidence of a membrane anchor or any significant hydrophobic regions (Skuce et al., 1999b) . These features would indicate that they should be processed into the water-soluble phase, yet this is apparently not the case -a hypothesis supported by the observation that protease-enriched preparations prepared from the water-soluble and membrane-associated phases of adult parasite extracts did not stimulate any degree of protective immunity in vaccine trials . One possibility is that these proteases are held in the membrane by association with the cystatin component of H-gal-GP.
Concluding Remarks
Clearly the commercial production of a vaccine against haemonchosis is quite feasible provided that the antigen(s) can be produced as recombinant proteins where the protective epitopes are expressed in an appropriate manner. To date, in the case of H11, H-gal-GP and TSBP, recombinant proteins expressed in E. coli have not induced significant protective immunity (E.A. Munn, D.P. Knox and W.D. Smith, 2000, unpublished results) , probably due to incorrect folding or a lack of glycosylation, or because more than one component was required. In the case of H11, protection obtained by vaccination with the native antigen is markedly reduced by dissociation and reduction. All three isoforms of H11 have been expressed as enzymically active recombinant proteins in Baculovirus and testing is ongoing. If successful, these trials will establish the principle of vaccinating against a gut nematode with a recombinant protein. However, Baculovirus is not an appropriate system for commercial vaccine production, hence there will still be a requirement to seek alternative expression systems.
The indications are that gut antigen-based vaccines, at least based on the antigens described above and mediated by high systemic antibody responses, are unlikely to be wholly effective against non-blood-feeding nematodes. Different antigens may be required and may need to be delivered in such a way as to stimulate local mucosal immune responses.
Future work will, inevitably, explore the possibility of DNA vaccination, a topic that has recently been the subject of a comprehensive review (Alarcon et al., 1999) . DNA vaccines are stable indefinitely and, potentially, obviate the need to perform much of the recombinant protein expression work referred to in the discussions above. DNA vaccines can induce protective cytotoxic T cell responses, helper T cell and humoral immunity and the immune response required can be modulated by co-administration with cytokine cDNAs and by using different modes and sites of delivery, including mucosal delivery. DNA vaccines can be based on single genes or entire expression libraries. DNA vaccination is certainly an attractive potential solution to the difficulties of developing recombinant vaccines based on multi-protein complexes such as H-gal-GP. We have already established that intramuscular delivery into sheep of hmcp6, as a cDNA cloned into pcDNA3 (Invitrogen), primed the immune system to produce a moderate antibody response to a single intramuscular injection of the corresponding recombinant protein. We now need to enhance this effect and to evaluate the responses to DNA vaccines containing all the components of H-gal-GP or TSBP, or combinations thereof.
